Shimadzu incorporates AI in new chromatograph series

Shimadzu's new Nexera UHPLC series with AI and IoT enhancements sets industry standard for intelligence, efficiency and ...

March 15, 2019 | Friday | News
Chugai’s Hemlibra receives approval for severe Hemophilia A

Chugai Pharmaceutical has announced that Roche received the decision from the European Commission confirming that Hemlib...

March 15, 2019 | Friday | News
Aprecia, CMIC to bring 3DP pharmaceutical products to Japan

Privately held Aprecia Pharmaceuticals, LLC (Aprecia) and CMIC CMO Co., LTD (CMIC CMO) have announced that both com...

March 15, 2019 | Friday | News
Fujifilm to acquire Biogen in a $890 M deal

FUJIFILM Corporation ("Fujifilm") announced that it has entered into an agreement to acquire Biogen (Denmark) Manufactur...

March 13, 2019 | Wednesday | News
FDA accepts NDA for Lemborexant to treat Insomnia

Eisai Co., Ltd. and Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Pu...

March 12, 2019 | Tuesday | News
Oncoceutics licenses rights for its anti-cancer compound to Ohara

US based Oncoceutics, Inc. has announced the outlicense of the rights to the company’s lead compound, ONC201, for ...

March 12, 2019 | Tuesday | News
In a first ever head-to-head biologic clinical study in Ulcerative Colitis Takeda's Entyvio demonstrates superior results compared to Humira

Takeda Pharmaceutical Company Limited has announced results from the Phase 3b head-to-head VARSITY study which demonstra...

March 11, 2019 | Monday | News
Akili, Shionogi to develop digital therapeutics in key Asian markets

Akili Interactive, digital medicine company creating prescription treatments for people living with cognitive dysfunctio...

March 11, 2019 | Monday | News
Santen to raise disease awareness during World Glaucoma Week

Santen Pharmaceutical Co., Ltd. (Santen) announced on March 8 that as part of its initiatives to increase publ...

March 8, 2019 | Friday | News
Eisai submits marketing authorization application for Insomnia drug

Eisai Co., Ltd. has announced that a marketing authorization application has been submitted in Japan for lemborexant, an...

March 7, 2019 | Thursday | News
Study: Inflammation in the brain enhances the side-effects of hypnotic medication

In a study recently published in the European Journal of Pharmacology researchers at Okayama University show h...

March 6, 2019 | Wednesday | News
Scientists develop stem cell-derived kidney tubules in microfluidic chips

Scientists from the Hubrecht Institute, the University of Utrecht, and MIMETAS have successfully grown kidney tubules de...

March 6, 2019 | Wednesday | News
Avita Medical to commercialize wounds treatment device in Japan

Australia based AVITA Medical, regenerative medicine company, announced that it has collaborated with COSMOTEC, an M3 Gr...

March 7, 2019 | Thursday | News
Novo Nordisk, Health2Sync collaborate for digital diabetes management

Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and fa...

March 5, 2019 | Tuesday | News
Sagent Pharma acquires Raleigh manufacturing site

Nichi-Iko Pharmaceutical and Sagent Pharmaceuticals, a Nichi-Iko Group Company, a leader of specialty pharmaceutical pro...

March 5, 2019 | Tuesday | News
AGC completes acquisition of Malgrat Pharma Chemicals

Tokyo based AGC Inc. has announced on March 4 the completion of its acquisition of Spain's synthetic...

March 4, 2019 | Monday | News
Thermo Fisher’s oncomine test receives expanded approval

Thermo Fisher Scientific recently announced that the Ministry of Health, Labour and Welfare (MHLW), Japan's regulatory a...

March 1, 2019 | Friday | News
CAC and rfxcel announce partnership for Pharmaceutical Traceability

CAC Corporation has signed a partnership agreement with rfxcel Corporation in the pharmaceutical traceability field...

February 28, 2019 | Thursday | News